Navellier & Associates’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,490
Closed -$501K 343
2021
Q4
$501K Buy
5,490
+282
+5% +$30.3K 0.07% 206
2021
Q3
$669K Buy
5,208
+252
+5% +$35.3K 0.1% 167
2021
Q2
$756K Buy
4,956
+1,027
+26% +$135K 0.11% 164
2021
Q1
$414K Buy
+3,929
New +$393K 0.07% 198

Other funds holding STAA

Navellier & Associates's STAA Position: Q1 2022 in Review

Navellier & Associates sold out of STAAR Surgical (STAA) in Q1 2022, closing a stake of 5,490 shares — an estimated $501K sold.

Navellier & Associates first reported a position in STAA in Q1 2021 and held it in 4 quarters. The position peaked at $756K in Q2 2021. 270 funds tracked by Wall St. Rank hold STAA as of Q1 2022.

  • Navellier & Associates reported no remaining STAAR Surgical position as of Q1 2022 after selling out during the quarter.
  • Navellier & Associates sold 5,490 STAAR Surgical shares in Q1 2022, an estimated $501K.
  • Navellier & Associates first reported a position in STAAR Surgical in Q1 2021 and held it in 4 quarters.
  • Navellier & Associates's STAAR Surgical position peaked at $756K in Q2 2021.
  • 270 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2022.

Based on Navellier & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.